These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 22313545

  • 21. Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.
    Jiang JX, Gao S, Pan YZ, Yu C, Sun CY.
    Mol Med Rep; 2014 Aug; 10(2):995-1002. PubMed ID: 24865963
    [Abstract] [Full Text] [Related]

  • 22. The synergistic effect of organic silicone quaternary ammonium salt and 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Wang JX, Zhang LY, Zhang J, Ding H, Wang DM, Wang ZP.
    Eur J Cancer Prev; 2014 Sep; 23(5):372-84. PubMed ID: 25072280
    [Abstract] [Full Text] [Related]

  • 23. Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway.
    Wu XL, Chen Y, Kong WC, Zhao ZQ.
    J Zhejiang Univ Sci B; 2014 Sep; 21(3):234-245. PubMed ID: 32133800
    [Abstract] [Full Text] [Related]

  • 24. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H, Jiang H, Zhou M, Xu Z, Liu S, Shi B, Yao X, Yao M, Gu J, Li Z.
    Cancer Lett; 2009 Jun 28; 279(1):30-8. PubMed ID: 19217205
    [Abstract] [Full Text] [Related]

  • 25. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W, Fang FF, Li B, Cheng BB, Ling CQ.
    Asian Pac J Cancer Prev; 2012 Jun 28; 13(9):4807-14. PubMed ID: 23167424
    [Abstract] [Full Text] [Related]

  • 26. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R, Xu LB, Yue XJ, Yu XH, Wang J, Liu C.
    Oncol Rep; 2013 Mar 28; 29(3):967-74. PubMed ID: 23242307
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, Guan XY.
    Gut; 2011 Apr 28; 60(4):534-43. PubMed ID: 21068133
    [Abstract] [Full Text] [Related]

  • 28. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M, Dong J, Wang Y, Zhang J, Zhang M, Wu Z, Lv Y, Wu R.
    Int J Biochem Cell Biol; 2018 Aug 28; 101():39-48. PubMed ID: 29800725
    [Abstract] [Full Text] [Related]

  • 29. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L, Wu L, Chen Z, Yang J, Chen X, Yu F, Zheng F, Lin X.
    Cell Physiol Biochem; 2015 Aug 28; 35(6):2333-48. PubMed ID: 25896253
    [Abstract] [Full Text] [Related]

  • 30. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S, Ono M, Yano H, Maruyama Y, Terada T, Yamada Y, Ueno T, Kojiro M, Hirano K, Kuwano M.
    Int J Oncol; 2006 Dec 28; 29(6):1469-78. PubMed ID: 17088986
    [Abstract] [Full Text] [Related]

  • 31. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 28; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 32. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
    Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1277-86. PubMed ID: 15709199
    [Abstract] [Full Text] [Related]

  • 33. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C, Zhao B, Long F, Liu Y, Liu Z, Li S, Yang X, Sun D, Wang H, Liu Q, Liang R, Li Y, Gao Z, Shao S, Miao QR, Wang L.
    Oncotarget; 2016 Feb 23; 7(8):8850-65. PubMed ID: 26840457
    [Abstract] [Full Text] [Related]

  • 34. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway.
    Zou X, Liang J, Sun J, Hu X, Lei L, Wu D, Liu L.
    J Pharmacol Sci; 2016 Aug 23; 131(4):233-40. PubMed ID: 27177453
    [Abstract] [Full Text] [Related]

  • 35. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
    Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y.
    Hepatology; 2006 Jul 23; 44(1):205-15. PubMed ID: 16799960
    [Abstract] [Full Text] [Related]

  • 36. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
    Zhang G, Zeng X, Zhang R, Liu J, Zhang W, Zhao Y, Zhang X, Wu Z, Tan Y, Wu Y, Du B.
    Phytomedicine; 2016 Nov 15; 23(12):1329-1336. PubMed ID: 27765352
    [Abstract] [Full Text] [Related]

  • 37. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.
    Oncol Rep; 2014 Jan 15; 31(1):216-22. PubMed ID: 24173654
    [Abstract] [Full Text] [Related]

  • 38. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis.
    Guo B, Xie N, Wang Y.
    Bull Cancer; 2015 Mar 15; 102(3):204-12. PubMed ID: 25747889
    [Abstract] [Full Text] [Related]

  • 39. H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.
    Li F, Wang J, Wu N, Zhang H, Li Z, Wei N.
    Biochem Biophys Res Commun; 2019 Nov 26; 520(1):93-98. PubMed ID: 31582208
    [Abstract] [Full Text] [Related]

  • 40. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.